U.S. flag

An official website of the United States government

PMC Full-Text Search Results

Items: 4

2.
Fig. 3

Fig. 3. From: Virological response and safety of 24-week telaprevir alone in Japanese patients infected with hepatitis C virus subtype 1b.

Changes in (a) hemoglobin, (b) uric acid, (c) LDL-cholesterol.

J Toyota, et al. J Viral Hepat. 2013 Mar;20(3):167-173.
3.
Fig. 1

Fig. 1. From: Virological response and safety of 24-week telaprevir alone in Japanese patients infected with hepatitis C virus subtype 1b.

HCV RNA kinetics during and after treatment with telaprevir monotherapy.

J Toyota, et al. J Viral Hepat. 2013 Mar;20(3):167-173.
4.
Fig. 4

Fig. 4. From: Virological response and safety of 24-week telaprevir alone in Japanese patients infected with hepatitis C virus subtype 1b.

Viral kinetics and predominant variants during and after telaprevir monotherapy beyond 8 weeks. Besides predominant clones, minority clones which account for 10% and more in a specimen are also summarized by brace notation. Putative secondary resistant-associated mutation is indicated by underline.

J Toyota, et al. J Viral Hepat. 2013 Mar;20(3):167-173.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center